Current Firm
Lux Capital
Investments
5+ companies
Focus
AI, Biotech
Peter co-founded Lux Capital during the dot-com crash to specifically back deep science and physical-world breakthroughs like nuclear waste remediation and advanced materials, deliberately avoiding software plays to focus on matter that matters. He personally conceived and built several portfolio companies from scratch around long-range theses, including Kurion in nuclear waste and Variant Bio in rare genetics, actively assembling the scientific teams and capital rather than simply backing existing founders.
Peter Hebert is a Co-Founder & Managing General Partner, Lux Capital at Lux Capital, based in New York, NY.
Peter's investment focus spans AI, Biotech, Aerospace & Defense, Space, Deeptech, primarily investing at the Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments in Peter's portfolio include Astranis, Relativity Space. These companies reflect a pattern of backing high-potential startups across their focus sectors.
Peter Hebert is a Co-Founder & Managing General Partner, Lux Capital at Lux Capital, based in New York, NY. Their investment focus includes AI, Biotech, Aerospace & Defense.
Peter Hebert focuses on investments in AI, Biotech, Aerospace & Defense, Space, Deeptech through Lux Capital. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Peter Hebert's notable portfolio investments include Medra, Anchorage, Astranis, Ironclad, Relativity Space. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Peter Hebert is currently at Lux Capital, headquartered in New York, NY, serving as Co-Founder & Managing General Partner, Lux Capital.